Clearone Inc (CLRO) · Oct 13, 2026 · Delisting
Delisting determination — $2.5M equity rule; hearing request due October 15
ClearOne’s delisting filing turns a known listing problem into a formal Nasdaq determination, with a hearing request due October 15.
ClearOne is no longer a normal operating hardware company: after selling substantially all of its conferencing and AV assets in October 2025, it is primarily maintaining legacy support, managing remaining assets and liabilities, pursuing strategic alternatives, and maintaining its public-company status. The listing problem has now escalated from warning to formal delisting determination. Nasdaq previously gave ClearOne until October 5, 2026 to cure its equity shortfall, but the Staff concluded the company still had not demonstrated the required $2.5 million of stockholders’ equity because the planned remedial actions were incomplete.
The appeal preserves a procedural path, not a solved problem. ClearOne intends to request a Nasdaq hearing by October 15, and that request would automatically stay suspension or delisting while the appeal proceeds. Without a timely request, trading would be suspended at the opening of business on October 19. 〔0〕 The direction was already known from the April deficiency notice and the extended cure period, so the new information is the failed remediation and formal Staff action—not the underlying risk.
This matters more because the listing is now one of ClearOne’s remaining strategic assets. With the historical product business largely gone, continued Nasdaq status supports the company’s ability to pursue a strategic transaction or other capital solution; losing it would further reduce market access and liquidity while the company is already operating under substantial financial pressure.
Bottom line: ClearOne has not been delisted immediately, but the company failed the cure process and must now win an appeal or produce a credible equity remedy. This materially worsens an already fragile post-asset-sale situation; the hearing request is the next decisive checkpoint.
Nasdaq hearing request due October 15, 2026
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!